ISRG vs TXG · P/E 80, rev $2.89B vs rev $301.9M
Intuitive Surgical Inc (ISRG) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported ISRG revenue for 2026-06-30 was $2.89B. Net income was $818.1M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
ISRG currently screens at market cap $195.15B and trailing P/E 80.0. TXG currently screens at market cap $4.08B.
Not investment advice. Open the ISRG and TXG stock pages for the full models.
Not investment advice.